The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity

The sanofi-aventis Group Thanks Its Team Members and Shareholders
and Launches Its New Visual Identity 


PARIS, Sept. 16  /PRNewswire-FirstCall/ -- The sanofi-aventis Group launched an
advertising campaign today in France, Germany and internationally to thank its
team members and shareholders for their help in the creation of the world's 3rd
largest pharmaceutical group.

"Thank you to the 100,000 team members and shareholders who helped create the

3rd largest pharmaceutical company in the world"

The campaign also publicly reveals the new visual identity of the new Group,
its logo, which will symbolize this new human endeavor around the world.

The new logo brings to mind the overriding goal that each and every member of
the Group shares: improving health.  Graphically, the logo block shows our
willingness to move forward together with a shared vision of the profession
that unites us.  It places all humanity, each and every individual, at the very
heart of our vocation and commitments.

  This logo consists of a symbol, a logo block, and a signature.

   - The symbol speaks to the heart of mankind and expresses solidarity.

   - The perfectly balanced, all-embracing curved line underscores the typo
     block of the sanofi-aventis name and symbolizes people joining
     together. Its color and rounded shape express humanistic values as well
     as the environment of scientific expertise in which we live.

   - Finally, the signature, « Because health matters », reminds all of us
     of our vocation and our commitment to enable the greatest number of
     people to gain access to medicines.



Yesterday, on September 15, 2004, the new visual identity was launched and
presented to all the 100,000 team members of the sanofi-aventis Group around
the world.  On every site, internal meetings were organized to reveal the logo
to all team members.  At the corporate Headquarters, the internal meeting was
chaired by Jean-François DEHECQ.

Further to the birth of the sanofi-aventis Group on August 20, 2004, and to the
announcement in early September of the appointment of a hundred managers
throughout the world, a new milestone has been reached in the integration
process of the new Group.

The sanofi-aventis Group is the world's 3rd largest pharmaceutical company,
ranking number 1 in Europe.  Backed by a world-class R&D organization,
sanofi-aventis is developing leading positions in seven major therapeutic
areas: cardiovascular disease, thrombosis, oncology, diabetes, central nervous
system, internal medicine, vaccines.

Important Information

In connection with its acquisition of Aventis, Sanofi-Aventis has announced
that it is studying the feasibility of merging Aventis with and into
Sanofi-Aventis, with Sanofi-Aventis continuing as the surviving corporation. In
connection with any merger of Aventis into Sanofi-Aventis, Sanofi-Aventis will
file a post-effective amendment to its registration statement on Form F-4 (File
no. 333-112314), which will include a prospectus relating to the merger, and
will file additional documents with the SEC.  Investors are urged to read the
registration statement, including any preliminary prospectus or definitive
prospectus (when available) relating to the merger, and any other relevant
documents filed with the SEC, including all amendments and supplements, because
they will contain important information.  Free copies of the registration
statement, as well as other relevant documents filed with the SEC, may be
obtained at the SEC's web site at http://www.sec.gov/.  At the appropriate
time, Sanofi-Aventis will provide investors with information on how to obtain
any merger-related documents for free from Sanofi-Aventis or from its duly
appointed agents.

   CONTACT:  Jean-Marc Podvin
             Vice President, Media Relations
             Sanofi-Aventis
             [phone]


DATASOURCE: sanofi-aventis Group



CONTACT:  Jean-Marc Podvin, Vice President, Media Relations of

Sanofi-Aventis, [phone]



Web site:  http://www.sanofi-aventis.com/ 



Company News On-Call:  http://www.prnewswire.com/comp/232375.html 

Copyright